Accuray (ARAY)
(Delayed Data from NSDQ)
$1.94 USD
-0.09 (-4.43%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $1.94 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value C Growth B Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ARAY 1.94 -0.09(-4.43%)
Will ARAY be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ARAY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ARAY
Accuray (ARAY), TrueNorth Unite to Aid Radiation Departments
Accuray's (ARAY) Precision TPS Gets Approved by China's NMPA
ARAY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inogen (INGN) Down 0.1% Since Last Earnings Report: Can It Rebound?
Accuray (ARAY) Up 2% Since Last Earnings Report: Can It Continue?
New Strong Sell Stocks for May 31st
Other News for ARAY
Heartland Value Fund Q2 2024 Portfolio Manager Commentary
Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care
Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients
Accuray partners with TrueNorth Medical to provide radiation oncology support
Accuray and TrueNorth Medical Physics partner in radiation oncology support